Cargando…
Characterization of PD-1/PD-L1 immune checkpoint expression in soft tissue sarcomas
Inhibitors of the programmed death-1/programmed death-ligand 1 (PD-1/PD-L1) immune checkpoint system are used for treating various malignancies. However, evidence on their use in soft tissue sarcomas (STS) is limited. This study aimed to retrospectively investigate the relationship between the expre...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273625/ https://www.ncbi.nlm.nih.gov/pubmed/34218652 http://dx.doi.org/10.4081/ejh.2021.3203 |